Cara Therapeutics
CARA
#10952
Rank
ยฃ6.19 M
Marketcap
ยฃ4.07
Share price
-2.56%
Change (1 day)
18.21%
Change (1 year)

EPS for Cara Therapeutics (CARA)

EPS in 2024 (TTM): -ยฃ16.45

According to Cara Therapeutics 's latest financial reports the company's current EPS (TTM) is -ยฃ16.05. In 2023 the company made an earnings per share (EPS) of -ยฃ19.99 a decrease over its 2022 EPS that were of -ยฃ14.58.

EPS history for Cara Therapeutics from 2013 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-ยฃ16.45-17.72%
2023-ยฃ19.9937.11%
2022-ยฃ14.58-8.09%
2021-ยฃ15.86
2019-ยฃ22.8320.87%
2018-ยฃ18.897.85%
2017-ยฃ17.51-9.05%
2016-ยฃ19.26110%
2015-ยฃ9.1717.65%
2014-ยฃ7.79-3.42%
2013-ยฃ8.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ5.10-131.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ0.54-103.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-ยฃ26.55 65.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-ยฃ38.44 139.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-ยฃ1.70-89.38%๐Ÿ‡บ๐Ÿ‡ธ USA